نتایج جستجو برای: ecstasy mdma

تعداد نتایج: 2964  

2016
Claudimir Lucio do Lago

A capillary electrophoresis tandem mass spectrometry method (CE-MS/MS) was developed for the determination of 3,4-methylenedioxymethamphetamine (3,4-MDMA) in Ecstasy tablets. In this study, Ecstasy tablets seized in Rio de Janeiro, Brazil, were homogenized and diluted before electrophoretic separation in 0.1 M formic acid electrolyte (pH 2.4) using a polyvinyl alcohol (PVA)-coated capillary. Se...

Journal: :Toxicology letters 2000
A S Christophersen

The methylenedioxy-derivatives of amphetamine and methamphetamine represent the largest group of designer drugs. The most frequently used compounds are 3,4-methylenedioxy-methamphetamine (MDMA-ecstasy) and 3,4-methylenedioxy-amphetamine (MDA), first synthesised in 1910 (MDA) and 1914 (MDMA), respectively, to be used as an appetite suppressant. At the end of the 1960s, non-medical (recreational)...

Journal: :British Dental Journal 2008

Journal: :Clinical journal of the American Society of Nephrology : CJASN 2008
Garland A Campbell Mitchell H Rosner

Ecstasy (MDMA, 3,4-methylenedioxymethamphetamine) is commonly used by college-aged individuals. Ecstasy leads to feelings of euphoria, emotional empathy, and increased energy. These effects come at a significant risk for complications. Ecstasy has been associated with acute kidney injury that is most commonly secondary to nontraumatic rhabdomyolysis but also has been reported in the setting of ...

2011
Dominik K Biezonski Jerrold S Meyer

High doses of the recreational drug 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") have been well-documented to reduce the expression of serotonergic markers in several forebrain regions of rats and nonhuman primates. Neuroimaging studies further suggest that at least one of these markers, the plasma membrane serotonin transporter (SERT), may also be reduced in heavy Ecstasy users. Such ef...

2011
Elena Puerta Norberto Aguirre

The amphetamine analogue 3,4-methylenedioxymethamphetamine (MDMA, ‘ecstasy’) is widely abused as a recreational drug due to its unique psychological effects. Of interest, MDMA causes long-lasting deficits in neurochemical and histological markers of the serotonergic neurons in the brain of different animal species. Such deficits include the decline in the activity of tryptophan hydroxylase in p...

Journal: :Human psychopharmacology 2014
Andrew C Parrott Derek G Moore John J D Turner Julia Goodwin Meeyoung O Min Lynn T Singer

OBJECTIVE The illicit recreational drug 3,4-methylenedioxymethamphetamine (MDMA) or Ecstasy has strong neurohormonal effects. When taken by recreational users at dance clubs and raves, it can generate an 800% increase in the stress hormone cortisol, whereas drug-free users show chronically raised levels of cortisol. The aim here is to critically debate this neurohormonal influence for the child...

2016
Kaeli Zimmermann Benjamin Becker

MDMA (3,4-methylenedioxymethamphetamine), often referred to as ‘ecstasy’, has been shown to selectively and persistently impair central serotonergic neurotransmission in laboratory animals. As of recent, evidence in human studies has suggested a link between recreational ecstasy use and a disruption of the brain’s serotonergic system. However, human neurocognitive and neuroimaging studies have ...

Journal: :Behavioural pharmacology 2011
Adam Stewart Russell Riehl Keith Wong Jeremy Green Jessica Cosgrove Karoly Vollmer Evan Kyzar Peter Hart Alexander Allain Jonathan Cachat Siddharth Gaikwad Molly Hook Kate Rhymes Alan Newman Eli Utterback Katie Chang Allan V Kalueff

3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') is a potent psychedelic drug inducing euphoria and hypersociability in humans, as well as hyperactivity and anxiety in rodents. Adult zebrafish (Danio rerio) have become a widely used species in neurobehavioral research. Here, we explore the effects of a wide range (0.25-120 mg/l) of acute MDMA doses on zebrafish behavior in the novel tank tes...

Journal: :Experimental and clinical psychopharmacology 2005
Catharine Montgomery John E Fisk Russell Newcombe Michelle Wareing Philip N Murphy

Previous research has demonstrated working memory and executive deficits in recreational users of MDMA (3,4-methylenedioxymethamphetamine; Ecstasy). In turn, both of these constructs have been implicated in syllogistic reasoning performance. Twenty-two MDMA users (mean age = 21.36) and 26 MDMA nonuser controls (mean age = 21.31) were tested on syllogisms of varying difficulty and on measures of...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید